Article
US FDA approves Regeneron's ultra-rare blood disease drug
Rating:
0.0
Views:
64
Likes:
1
Library:
1
Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare blood disease.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value